tradingkey.logo

Genenta Science SPA

GNTA
2.460USD
+0.160+6.96%
Close 11/05, 16:00ETQuotes delayed by 15 min
47.10MMarket Cap
--P/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-15.01%-3.86M
73.41%-1.90M
23.95%-3.36M
-177.84%-7.16M
---4.42M
---2.58M
Net income from continuing operations
0.56%-4.50M
41.49%-3.73M
21.86%-4.53M
-200.99%-6.38M
---5.79M
---2.12M
Operating gains losses
4.74%20.68K
2.50%20.46K
552.03%19.74K
606.99%19.96K
--3.03K
--2.82K
Other non-cash items
-10.59%29.00K
-23.67%29.32K
-45.83%32.43K
55.73%38.41K
--59.87K
--24.66K
Change in working capital
-97.32%21.90K
227.76%1.57M
-6.78%815.87K
-69.29%-1.23M
--875.22K
---723.91K
-Change in prepaid expenses
15.23%-138.48K
311.87%755.46K
-122.14%-163.37K
70.83%-356.58K
--737.78K
---1.22M
-Change in other current assets
-93.02%71.05K
221.45%575.79K
228.46%1.02M
-206.61%-474.11K
---792.77K
--444.71K
-Change in other current liabilities
-253.27%-110.83K
269.63%183.49K
-13.17%72.31K
-141.48%-108.17K
--83.28K
--260.75K
Cash from non-recurring investing activities
Cash from operating activities
-15.01%-3.86M
73.41%-1.90M
23.95%-3.36M
-177.84%-7.16M
---4.42M
---2.58M
Investing cash flow
Net cash from continuing investing activities
91.35%2.40K
-85.28%1.73K
-94.32%1.25K
315.87%11.74K
--22.08K
--2.82K
Capital expenditures
91.35%2.40K
-85.28%1.73K
-94.32%1.25K
315.87%11.74K
--22.08K
--2.82K
Net cash flow from disposal of fixed assets
91.35%2.40K
-85.28%1.73K
-94.32%1.25K
315.87%11.74K
--22.08K
--2.82K
Net cash flow from investment products
152.71%2.39M
142.17%3.98M
---4.53M
---9.43M
----
----
Cash from non-current investing activities
Net cash flow from investing activities
152.65%2.39M
142.10%3.97M
-20426.51%-4.53M
-334332.69%-9.44M
---22.08K
---2.82K
Financing cash flow
Cash flow from continuous financing activities
-100.00%0.00
--250.40K
--491.99
--0.00
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
----
----
----
----
----
--0.00
Proceeds from stock option exercised by employees
----
----
----
----
--0.00
--0.00
Net cash flow from other financing activities
-100.00%0.00
--250.40K
--491.99
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.00%0.00
--250.40K
--491.99
--0.00
--0.00
--0.00
Net cash flow
Beginning cash balance
-49.49%5.72M
-87.87%3.41M
-64.14%11.32M
-24.74%28.13M
--31.56M
--37.37M
Current period cash flow changes
81.21%-1.48M
113.90%2.31M
-77.90%-7.90M
-543.74%-16.60M
---4.44M
---2.58M
Effect of exchange rate changes
-16.95%-6.80K
---14.87K
---5.82K
----
----
----
Ending cash balance
23.73%4.23M
-50.39%5.72M
-87.39%3.42M
-66.87%11.53M
--27.12M
--34.80M
Free cash flow
-15.04%-3.86M
73.43%-1.90M
24.30%-3.36M
-178.00%-7.17M
---4.44M
---2.58M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI